MedPath

Butalbital, Aspirin and Caffeine

Butalbital, Aspirin, and Caffeine Tablets, USP CIIIRev. 04/03Rx Only

Approved
Approval ID

4e10129b-41a3-4572-9564-6f8366b627dc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 10, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Butalbital, Aspirin and Caffeine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-354
Application NumberANDA086162
Product Classification
M
Marketing Category
C73584
G
Generic Name
Butalbital, Aspirin and Caffeine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 8, 2009
FDA Product Classification

INGREDIENTS (6)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
BUTALBITALActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
ASPIRINActive
Quantity: 325 mg in 1 1
Code: R16CO5Y76E
Classification: ACTIB
CAFFEINEActive
Quantity: 40 mg in 1 1
Code: 3G6A5W338E
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Butalbital, Aspirin and Caffeine - FDA Drug Approval Details